This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
AstraZeneca PLC has spun out its gastrointestinal therapeutics business into a new company called Albireo Pharmaceutical. AZ, along with Nomura Phase4 Ventures, TVM Capital, and Scottish Widows Investment Partnership, provided $27mm in funding to the new entity in a Series A round that is expected to reach $40mm in the near future.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?